1. Home
  2. RYTM vs KTB Comparison

RYTM vs KTB Comparison

Compare RYTM & KTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • KTB
  • Stock Information
  • Founded
  • RYTM 2008
  • KTB 2018
  • Country
  • RYTM United States
  • KTB United States
  • Employees
  • RYTM N/A
  • KTB N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • KTB Apparel
  • Sector
  • RYTM Health Care
  • KTB Consumer Discretionary
  • Exchange
  • RYTM Nasdaq
  • KTB Nasdaq
  • Market Cap
  • RYTM 3.2B
  • KTB 3.5B
  • IPO Year
  • RYTM 2017
  • KTB N/A
  • Fundamental
  • Price
  • RYTM $57.24
  • KTB $57.31
  • Analyst Decision
  • RYTM Strong Buy
  • KTB Strong Buy
  • Analyst Count
  • RYTM 12
  • KTB 6
  • Target Price
  • RYTM $73.58
  • KTB $91.50
  • AVG Volume (30 Days)
  • RYTM 795.0K
  • KTB 906.6K
  • Earning Date
  • RYTM 05-06-2025
  • KTB 05-01-2025
  • Dividend Yield
  • RYTM N/A
  • KTB 3.46%
  • EPS Growth
  • RYTM N/A
  • KTB 7.39
  • EPS
  • RYTM N/A
  • KTB 4.36
  • Revenue
  • RYTM $130,126,000.00
  • KTB $2,607,578,000.00
  • Revenue This Year
  • RYTM $45.46
  • KTB $2.70
  • Revenue Next Year
  • RYTM $63.04
  • KTB $2.69
  • P/E Ratio
  • RYTM N/A
  • KTB $13.77
  • Revenue Growth
  • RYTM 68.06
  • KTB 0.00
  • 52 Week Low
  • RYTM $35.17
  • KTB $50.00
  • 52 Week High
  • RYTM $68.58
  • KTB $96.80
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 48.62
  • KTB 27.35
  • Support Level
  • RYTM $45.91
  • KTB $62.57
  • Resistance Level
  • RYTM $63.11
  • KTB $66.92
  • Average True Range (ATR)
  • RYTM 3.46
  • KTB 3.16
  • MACD
  • RYTM 0.29
  • KTB -0.59
  • Stochastic Oscillator
  • RYTM 36.33
  • KTB 15.95

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About KTB Kontoor Brands Inc.

Kontoor Brands Inc is a lifestyle apparel company. It is engaged in designing, manufacturing, sourcing, marketing, and distribution of its portfolio of brands, including Wrangler and Lee. It manufactures its products in owned and leased facilities and distributes the products through both brick-and-mortar and e-commerce retailers. The Company has two reportable segments: Wrangler and Lee. It generates the majority of its revenue from the Wrangler segment. The company's geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

Share on Social Networks: